NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
March 01 2024 - 7:05AM
Business Wire
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology
testing services company, today announced the company will
participate in the upcoming TD Cowen 44th Annual Health Care
Conference in Boston, Massachusetts.
Members of NeoGenomics’ management team will participate in a
fireside chat on Tuesday, March 5th at 9:10 a.m. ET. A live and
archived audio webcast of the presentation will be available on the
“News, Events, and Webcasts” tab via the Investor Relations section
of the Company’s website at ir.neogenomics.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and
information services, providing one of the most comprehensive
oncology-focused testing menus for physicians to help them diagnose
and treat cancer. The Company's Advanced Diagnostic Division also
serves pharmaceutical clients in clinical trials and drug
development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP
accredited and CLIA certified laboratories for full-service sample
processing in Fort Myers, Florida; Aliso Viejo and San Diego,
California; Research Triangle Park, North Carolina; and Houston,
Texas; and a CAP accredited full-service, sample-processing
laboratory in Cambridge, United Kingdom. NeoGenomics also has
several, small, non-processing laboratory locations across the
United States for providing analysis services. NeoGenomics serves
the needs of pathologists, oncologists, academic centers, hospital
systems, pharmaceutical firms, integrated service delivery
networks, and managed care organizations throughout the United
States, and pharmaceutical firms in Europe and Asia.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240301059734/en/
Investor Contact Kendra Sweeney
kendra.sweeney@neogenomics.com
Media Contact Andrea Sampson
asampson@sampsonprgroup.com
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Jun 2024 to Jul 2024
NeoGenomics (NASDAQ:NEO)
Historical Stock Chart
From Jul 2023 to Jul 2024